JOHN KIRKWOOD to Fibroblast Growth Factor 2
This is a "connection" page, showing publications JOHN KIRKWOOD has written about Fibroblast Growth Factor 2.
Connection Strength
0.446
-
ECOG phase II trial of graded-dose peginterferon a-2b in patients with metastatic melanoma overexpressing basic fibroblast growth factor (E2602). Clin Cancer Res. 2013 Dec 01; 19(23):6597-604.
Score: 0.437
-
Molecular analysis of melanoma precursor lesions. Cell Growth Differ. 1996 Dec; 7(12):1733-40.
Score: 0.008